Avenue Therapeutics May Offer Shares Of Common Stock Having Offering Price Of Up To $3.9M From Time To Time Through Agent

Avenue Therapeutics May Offer Shares Of Common Stock Having Offering Price Of Up To $3.9M From Time To Time Through Agent

BenzingaMay 11 04:56

Avenue Capital Group Closes on Over $1 Billion in Commitments for European Strategy Targeting Asset-Backed Lending Opportunities

NEW YORK and LONDON, May 9, 2024 /PRNewswire/ -- Avenue Capital Group today announced the successful final closing of the Avenue Europe Special Situations Fund V (the "Avenue Europe Fund"). Together

PR NewswireMay 9 19:00

Avenue Therapeutics Files to Sell 1.42M Shares

Seeking AlphaMay 7 03:14

Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday's session after the company announced that it will voluntarily delist its common shares from the Nasdaq and deregister it

BenzingaApr 30 01:04

FLGC, BTOG and CAUD Among Mid-day Movers

Seeking AlphaApr 30 00:31

Why Avenue Therapeutics (ATXI) Stock Is Falling Sharply

Avenue Therapeutics (NASDAQ:ATXI) shares are trading lower by 20.7% to $4.92 during Monday's session after the company announced the exercise of warrants for $4.4 million in gross proceeds.These warra

BenzingaApr 29 22:59